Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging: the MDS (Melanoma Detecting System)

NCT02056522 is registered in ClinicalTrials.gov with Orlucent, Inc as lead sponsor.

NCT NCT02056522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02056522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging: the MDS (Melanoma Detecting System)
Lead sponsor
Orlucent, Inc
Phase
Observational
Overall status
Completed
Start date
July 31, 2016
Completion date
July 31, 2018
Enrollment
357 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

skin lesions